RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENTResearch and Development Collaboration and License Agreement • March 28th, 2013 • Zoetis Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2013 Company Industry JurisdictionTHIS RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT (the "Agreement") is made effective as of February 6, 2013 (the "Effective Date"), by and between Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 ("Pfizer") and Zoetis Inc., a Delaware corporation having its principal place of business at 5 Giralda Farms, Madison, NJ 07940 (the "Company"). Pfizer and the Company are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT – ABL 001Research and Development Collaboration and License Agreement • August 16th, 2021 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 16th, 2021 Company IndustryTHIS RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT-ABL 001 (including the schedules and appendix hereto, this “Agreement”), effective as of November 30, 2018 (the “Effective Date”), is between: